Cellular Biomedicine Group Inc (NASDAQ:CBMG)

Delayed Data
As of Feb 16
 +0.60 / +3.35%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Cellular Biomedicine Group Inc have a median target of 18.00, with a high estimate of 18.00 and a low estimate of 18.00. The median estimate represents a -2.70% decrease from the last price of 18.50.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Cellular Biomedicine Group Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.98%
Growthannually 33.97%


Growthquarterly --
Growthannually -74.36%
Key to the earnings and sales forecast charts.